Biotech Stocks to Keep an Eye-On (AMLN, GILD, GENZ, THRX)
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) dropped 1.29% to $13.05. Last week, U.S. regulators said they won’t consider approving the companies’ new diabetes drug Bydureon until they submit additional clinical studies. Bydureon is a long-acting formulation of Amylin’s popular diabetes medication Byetta. The stock went down more than 7% year-to-date. Gilead Sciences, Inc. (NASDAQ:GILD) fell 0.35% to [...]
Top Biotech Stock Gainers (BIIB, GENZ, AMGN, CELG)
Biogen Idec Inc. (NASDAQ:BIIB) gained 1.15% to $55.42. Biogen Idec Inc. is a global biotechnology company. The products of the Company include AVONEX, RITUXAN, TYSABRI and FUMADERM. The Company’s products address diseases, such as multiple sclerosis (MS), non-Hodgkin’s lymphoma (NHL), rheumatoid arthritis (RA), Crohn’s disease (CD) and psoriasis. Today, the stock opened at $55.17 and [...]